<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DBD8FC73-90C8-40C5-AAD9-A3C601B4DDF7"><gtr:id>DBD8FC73-90C8-40C5-AAD9-A3C601B4DDF7</gtr:id><gtr:name>Syngenta Ltd</gtr:name><gtr:address><gtr:line1>Environmental Safety</gtr:line1><gtr:line2>Jealotts Hill International Centre</gtr:line2><gtr:line4>Bracknell</gtr:line4><gtr:postCode>RG42 6EY</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DF0020F8-9212-4670-ADC0-CBDFF5B93548"><gtr:id>DF0020F8-9212-4670-ADC0-CBDFF5B93548</gtr:id><gtr:name>GlaxoSmithKline</gtr:name><gtr:address><gtr:line1>Stockley Park West</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:postCode>UB11 1BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F327D9BD-7240-42B0-85D7-28BE87B9576C"><gtr:id>F327D9BD-7240-42B0-85D7-28BE87B9576C</gtr:id><gtr:name>Novartis Pharma AG</gtr:name><gtr:address><gtr:line1>WKL - 136.5.22</gtr:line1><gtr:line4>Basel</gtr:line4><gtr:line5>CH 4002</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/84EC36D9-AAC8-496A-B69B-F9DE2213B154"><gtr:id>84EC36D9-AAC8-496A-B69B-F9DE2213B154</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4F35B66C-1E8B-4FEC-AD93-B385DA11E2D8"><gtr:id>4F35B66C-1E8B-4FEC-AD93-B385DA11E2D8</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Brown</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/71E0A904-423D-41A8-A79D-3954B8B5D4FC"><gtr:id>71E0A904-423D-41A8-A79D-3954B8B5D4FC</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Russell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FE9E2933-6D5D-48C1-AE88-2C6BE7620CA7"><gtr:id>FE9E2933-6D5D-48C1-AE88-2C6BE7620CA7</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Harrowven</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8E16681F-5AB4-4AEC-B1E8-40ED46301A01"><gtr:id>8E16681F-5AB4-4AEC-B1E8-40ED46301A01</gtr:id><gtr:firstName>Guy</gtr:firstName><gtr:surname>Lloyd-Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/68131F25-8218-48DF-872C-8458EEDC715E"><gtr:id>68131F25-8218-48DF-872C-8458EEDC715E</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Ross</gtr:otherNames><gtr:surname>Carbery</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A0731652-EA3E-427F-ADE1-60720C321A25"><gtr:id>A0731652-EA3E-427F-ADE1-60720C321A25</gtr:id><gtr:firstName>Lotte Susanne</gtr:firstName><gtr:surname>Coles</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BD5D48DE-CBD6-4DF7-B28C-012C263F1240"><gtr:id>BD5D48DE-CBD6-4DF7-B28C-012C263F1240</gtr:id><gtr:firstName>Kevin</gtr:firstName><gtr:otherNames>Iain</gtr:otherNames><gtr:surname>Booker-Milburn</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FL003325%2F1"><gtr:id>47A5807A-C882-4738-B8FC-91DAE932A975</gtr:id><gtr:title>Factory in a Fumehood: Reagentless Flow Reactors as Enabling Techniques for Manufacture</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/L003325/1</gtr:grantReference><gtr:abstractText>This proposal aims to bring together a unique team of scientists from academia and industry to develop new enabling manufacturing techniques for the reagentless synthesis of high value chemical products. Why reagentless? In traditional chemical processes once a reagent has performed its task it needs to be removed from the product stream. Unless the spent reagent can be reactivated then the waste stream must be dealt with. Most processes require large amounts of reagent, placing a heavy financial and environmental burden on manufacturing of high value products such as pharmaceuticals. The Holy Grail would be to avoid reagents altogether. Photochemisty, electrochemistry and thermochemistry are reagentless techniques, requiring only electrical energy as a primary input and will be the focus of this project in order to provide new enabling techniques for manufacturing. By the use of flow chemistry techniques these three areas can be connected together to provide rapid access to complex, high value products - this is conceptualized as a 'Factory in a Fumehood' - where scale-up can be achieved with a small footprint and with greatly reduced operating costs and waste.</gtr:abstractText><gtr:potentialImpactText>Manufacturing in the UK and Europe has suffered enormously over the past decade. The availability of cheap labour and the proliferation of CRO's in Asia has resulted in the outsourcing of both R&amp;amp;D and Manufacture. This has been particularly acute in the Pharmaceutical and Fine Chemical industries, in both of which the UK are world leading. The key problem is the high operational and depreciation costs associated with R&amp;amp;D labs and fixed manufacturing plants. Development of the reagentless flow chemistry techniques described herein will generate small footprint, portable reactors that can be housed in fumehoods. The 'Factory in a Fumehood' concept has been inspired by Berry and GSK colleagues who recently built a plant that is capable of manufacturing a product worth &amp;pound;6Bn per annum. This continuous process has a footprint of just 4-fumehoods and will shortly be reduced to manufacturing practice at an estimated cost of &amp;pound;5M. With such relatively trivial set-up and operating costs why outsource? Indeed, the recent GSK developments have the manufacturing capability of a conventional chemical manufacturing plant. The 'Factory in a Fumehood' concept has the real potential to create both jobs (in science and engineering and supporting areas) and wealth in the UK. At a fundamental level ready access to turnkey technologies that embody our reagentless techniques will have a profound impact on the chemical design philosophies of industrial chemists. This in turn will lead to the manufacture of new high value chemical products, creating new IP space. An added benefit will be the creation of commercial opportunities for UK based equipment design and manufacture to support the chemical manufacturing objectives.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2013-10-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>940746</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Research and Development AstraZeneca</gtr:department><gtr:description>Factory in a Fumehood Project</gtr:description><gtr:id>4B96C142-8BC3-46EB-9094-054E481A80A9</gtr:id><gtr:impact>Publications, reactor development, reactor commercialisation, patent preparation</gtr:impact><gtr:outcomeId>56d971d2e111a3.61439290-2</gtr:outcomeId><gtr:partnerContribution>Chemistry Face to Face meeting venues. In-house chemistry projects/outsourcing/ reactor trialling</gtr:partnerContribution><gtr:piContribution>Reactor engineering advice. Scale-up of photochemistry and electrochemistry.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>GlaxoSmithKline Medicines Research Centre</gtr:department><gtr:description>Factory in a Fumehood Project</gtr:description><gtr:id>7536E8C3-5997-4100-A312-374129DD49B1</gtr:id><gtr:impact>Publications, reactor development, reactor commercialisation, patent preparation</gtr:impact><gtr:outcomeId>56d971d2e111a3.61439290-1</gtr:outcomeId><gtr:partnerContribution>Chemistry Face to Face meeting venues. In-house chemistry projects/outsourcing/ reactor trialling</gtr:partnerContribution><gtr:piContribution>Reactor engineering advice. Scale-up of photochemistry and electrochemistry.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation to Flow Chemistry Europe Cambridge 7/2/17</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1137F82D-E4E0-4009-9564-AC65152B745F</gtr:id><gtr:impact>Invited Presentation to two day Flow Chemistry Europe conference in Cambridge 7/2/17</gtr:impact><gtr:outcomeId>58c158647fb909.61669632</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation and Research Collaboration Discussion at Syngenta Stein (Switzerland)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E3554C82-964C-4675-B686-73564DB5A077</gtr:id><gtr:impact>A research lecture on Photochemical Synthesis followed by a round table discussion on future collaboration in this area</gtr:impact><gtr:outcomeId>58c1555f53d209.68747644</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UKASF Invited Lecture 7/11/16</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A32817DE-7B2C-4BBB-A800-6A138309A532</gtr:id><gtr:impact>Invited lecture on Photochemical technology to UK Automated Synthesis Forum</gtr:impact><gtr:outcomeId>58c1560e91c883.29179413</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hans Schutszy Symposium Salford 29/4/16</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>CE5903CC-EB7F-417D-82C1-30BB4552B6E8</gtr:id><gtr:impact>Invited speaker at Synthetic Chemistry Symposium held in Honour of late Professor Hans Schutszy</gtr:impact><gtr:outcomeId>58c1543bcd7719.93431250</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FiaF Presentation to Process Development at Astra Zeneca Macclesfield 18/1/17</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6C60295C-DA49-4329-9DAC-98466DEFAAB7</gtr:id><gtr:impact>Lecture to update on AZ staff (not involved in FiaF) of the outputs of the grant</gtr:impact><gtr:outcomeId>58c156e0a341e2.75913498</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentations to Eli Lilly Chemists on Photochemical Technology and Synthesis 27/4/16</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4246BF34-08BE-42DF-94FD-B4C1ED400613</gtr:id><gtr:impact>Delivered 2 lectures to Lilly Chemists (UK) on Photochemical Synthesis and then Photochemical Technology and Methods. Video link to another site in Spain.</gtr:impact><gtr:outcomeId>58c15362d8cb16.16258659</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FiaF Presentation to Process Development at GSK Stevenage 22/4/16</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A5BD4E96-C9C8-4D5D-9474-11343DAAE1B6</gtr:id><gtr:impact>Presentation of outputs and know-how from grant to ~80 Process Chemists</gtr:impact><gtr:outcomeId>58c15290db3214.17657233</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Final FiaF Presentation to Process Development at GSK Stevenage 3/2/17</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5827D827-839D-4A07-9354-41DED6112332</gtr:id><gtr:impact>Dissemination of final outputs of FiaF grant to a wider GSK audience (with 2 other speakers in a mini-symposium)</gtr:impact><gtr:outcomeId>58c1578c40e633.09183546</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>265000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Lilly Research Awards Programme</gtr:description><gtr:fundingOrg>Eli Lilly &amp; Company Ltd</gtr:fundingOrg><gtr:id>43A72D7F-DDFB-4DD6-8C92-B8BA4ACE91FA</gtr:id><gtr:outcomeId>56e02499a81a41.49917098</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6486390</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Photo-Electro: Transforming Chemical Synthesis, Discovery and Manufacture</gtr:description><gtr:end>2022-02-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/P013341/1</gtr:fundingRef><gtr:id>D4F79305-F9BD-4A24-9AED-02CA7974223B</gtr:id><gtr:outcomeId>58c00b6d07a435.21455173</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Eli Lilly CASE award</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Eli Lilly &amp; Company Ltd</gtr:fundingOrg><gtr:fundingRef>EP/G036764/1</gtr:fundingRef><gtr:id>BDF2FD6C-C190-4CE5-8894-2A3A6204A199</gtr:id><gtr:outcomeId>56d9b8a3507212.03435479</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>33000</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cambridge Reactor Design</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Cambridge Reactor Design</gtr:fundingOrg><gtr:id>BCEAD50B-536D-467D-AFE0-DC0F344ED06E</gtr:id><gtr:outcomeId>56e025555df2e2.55212427</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>'The Ammonite', a commercial continuous flow electrochemical reactor will be launched by Cambridge Reactor Design on 1/11/16. This reactor was developed by Brown, Green, Harrowven and Pletcher at Southampton University Chemistry Department as a key objective of the award.
 
The successful development of the Firefly represents the first research laboratory scale photochemical reactor capable of producing over a kg of product per day. This capability and products produced by the Firefly photochemical reactor may be of interest to clients through our recently launched Photodiversity spin-out company. A patent was filed in July 2016.

The reactors have been used to investigate some select GSK and AZ processes and further followups are being discussed.</gtr:description><gtr:firstYearOfImpact>2016</gtr:firstYearOfImpact><gtr:id>B9A5CC10-4CF4-4371-BBD8-0929535162F5</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56d5a7eacf0c35.67538192</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Chemicals,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have successfully developed operating flow photochemical and electrochemical reactors and have demonstrated their potential to synthesise over a kilogram of material in 24h. The electrochemical reactor is being commercialised and a patent application has been filed for the photochemical reactor.</gtr:description><gtr:exploitationPathways>Once fully developed and implemented the new reactors will enable the scale up of photochemistry and electrochemical synthesis in process and manufacture in pharma and agrochemical industries. The electrochemical reactor will be commercialised on 1/5/16 (see narrative) and the photochemical reactor is currently being patented. The photochemical reactor will contribute to our recently launched Photodiversity spin-out company.</gtr:exploitationPathways><gtr:id>74712FC9-54E7-434B-9CFA-DEDEA7843482</gtr:id><gtr:outcomeId>56c1f103cb8671.32122331</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Chemicals,Education,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This grant has resulted in two new reactors for chemical synthesis.

1. The Ammonite is high capacity (kg/day) flow reactor for electrochemical synthesis and is currently available for sale by Cambridge Reactor Design
2. The Firefly is a high capacity (&amp;gt;kg/day) flow reactor for photochemical synthesis. A Patent has been filed and is currently under assessment.</gtr:description><gtr:id>9484756E-DA2C-49FD-8A4C-EF81D1CB5891</gtr:id><gtr:impact>Commercialisation of Ammonite reactors.
Firefly reactor impact on Photodiversity start-up company (Booker-Milburn)</gtr:impact><gtr:outcomeId>58c16afbc19d76.97988390</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Development of New Reactors for Chemical Synthesis</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>'The Ammonite', a commercial continuous flow electrochemical reactor was launched by Cambridge Reactor Design on 1/5/17. This reactor was developed by Brown, Green, Harrowven and Pletcher at Southampton University Chemistry Department as a key objective of the award.</gtr:description><gtr:id>B5C5FE11-9FCA-4134-BEC5-53CC9720AD99</gtr:id><gtr:impact>3 (?) Ammonite Reactors have been sold to date</gtr:impact><gtr:outcomeId>56d86135051431.24643909</gtr:outcomeId><gtr:title>The Ammonite continuous electrochemical reactor</gtr:title><gtr:type>New/Improved Technique/Technology</gtr:type><gtr:url>http://www.cambridgereactordesign.com/ammonite/</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Photodiversity Limited</gtr:companyName><gtr:description>A start up company to serve the Pharma, Biotech and Agrochem industries by production of novel and proprietary fragment, focussed and diversity libraries for use in drug discovery, in collaboration and for commercialisation. USP: Photochemically-derived moelcules produced using novel technologies and chemistries. Two part model: Universities of Bristol and Sussex</gtr:description><gtr:id>5D3823CA-7003-497F-B05E-6F87CEFAB7E9</gtr:id><gtr:impact>Since trading started in November 2015, 2 POs have been completed with international clients and several more are ongoing.</gtr:impact><gtr:outcomeId>56d6ccfdf03ef9.19798460</gtr:outcomeId><gtr:yearCompanyFormed>2015</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>4E4851D7-5632-46EE-B18B-0D76D2AF32F6</gtr:id><gtr:title>Short Flow-Photochemistry Enabled Synthesis of the Cytotoxic Lactone (+)-Goniofufurone.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c430208c6adbf3bc30337ba642ec5e3"><gtr:id>4c430208c6adbf3bc30337ba642ec5e3</gtr:id><gtr:otherNames>Ralph M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>56d6c959949d40.08532275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD13D4A4-07B2-49CF-836A-DCE182DD6D0C</gtr:id><gtr:title>Using batch reactor results to calculate optimal flow rates for the scale-up of UV photochemical reactions</gtr:title><gtr:parentPublicationTitle>Reaction Chemistry &amp; Engineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffa4a5d7aca1a6b4dae0787ec9533a89"><gtr:id>ffa4a5d7aca1a6b4dae0787ec9533a89</gtr:id><gtr:otherNames>Elliott L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a6707cfd795e3.61030515</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E36B91BC-DB52-43CA-B939-0EF3B00D02C6</gtr:id><gtr:title>N-Heterocyclic Carbene-Mediated Oxidative Electrosynthesis of Esters in a Microflow Cell.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/974200e05f730cdc6460e18bfbe150d8"><gtr:id>974200e05f730cdc6460e18bfbe150d8</gtr:id><gtr:otherNames>Green RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>5675e678d1e6c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E91EC55E-C37D-4E68-94D6-FB5E525E82A7</gtr:id><gtr:title>Batch versus flow photochemistry: a revealing comparison of yield and productivity.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2d7ee0a063f07e33c999da3e1d60052"><gtr:id>e2d7ee0a063f07e33c999da3e1d60052</gtr:id><gtr:otherNames>Elliott LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>560a700d129ec7.47687002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E4CB2C9-4CF7-49FE-BCF3-5B649052E5FB</gtr:id><gtr:title>Electrochemical Deprotection of para-Methoxybenzyl Ethers in a Flow Electrolysis Cell.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/974200e05f730cdc6460e18bfbe150d8"><gtr:id>974200e05f730cdc6460e18bfbe150d8</gtr:id><gtr:otherNames>Green RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>5a2fe70072e1d5.94412801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E810B10D-921B-43FF-930A-59C0A3FD50F1</gtr:id><gtr:title>Understanding the Performance of a Microfluidic Electrolysis Cell for Routine Organic Electrosynthesis</gtr:title><gtr:parentPublicationTitle>Journal of Flow Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/790e9af20d6656f8af337a471ec2d7ee"><gtr:id>790e9af20d6656f8af337a471ec2d7ee</gtr:id><gtr:otherNames>Green R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56e044c28a00b1.03588094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C5A15C4-5D67-4CE8-ACC4-52B5EC2ED644</gtr:id><gtr:title>N-Heterocyclic Carbene-Mediated Microfluidic Oxidative Electrosynthesis of Amides from Aldehydes.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/974200e05f730cdc6460e18bfbe150d8"><gtr:id>974200e05f730cdc6460e18bfbe150d8</gtr:id><gtr:otherNames>Green RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>56e044c2d919b2.13760038</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B26FF304-89CA-4636-B54B-4B0CBFBAD56E</gtr:id><gtr:title>Conformationally Driven Two- and Three-Photon Cascade Processes in the Stereoselective Photorearrangement of Pyrroles.</gtr:title><gtr:parentPublicationTitle>Organic letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3be2ea59bdae701da9b40884c62f738e"><gtr:id>3be2ea59bdae701da9b40884c62f738e</gtr:id><gtr:otherNames>Koovits PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1523-7052</gtr:issn><gtr:outcomeId>585d7618d55e35.34052374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEF735B2-F824-42EC-9C59-1CB1EC08DA88</gtr:id><gtr:title>A Microflow Electrolysis Cell for Laboratory Synthesis on the Multigram Scale</gtr:title><gtr:parentPublicationTitle>Organic Process Research &amp; Development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/790e9af20d6656f8af337a471ec2d7ee"><gtr:id>790e9af20d6656f8af337a471ec2d7ee</gtr:id><gtr:otherNames>Green R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56e044c2b13816.54493627</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD7432D6-C164-4439-8898-2913CDCE82B1</gtr:id><gtr:title>Combining photochemistry and catalysis: rapid access to sp
 
 - rich polyheterocycles from simple pyrroles</gtr:title><gtr:parentPublicationTitle>Chemical Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c03e44205dfe84f4887399a521a9d2a"><gtr:id>2c03e44205dfe84f4887399a521a9d2a</gtr:id><gtr:otherNames>Blackham E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56d6c9e426d080.27923058</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56571091-2B7E-4594-B6D7-64D5B7018B4A</gtr:id><gtr:title>A Small-Footprint, High-Capacity Flow Reactor for UV Photochemical Synthesis on the Kilogram Scale</gtr:title><gtr:parentPublicationTitle>Organic Process Research &amp; Development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffa4a5d7aca1a6b4dae0787ec9533a89"><gtr:id>ffa4a5d7aca1a6b4dae0787ec9533a89</gtr:id><gtr:otherNames>Elliott L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d75cc9f74a5.06237002</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88E6A298-ACE9-469C-A592-3787698BEF9F</gtr:id><gtr:title>Real-Time Biological Annotation of Synthetic Compounds.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe2e48115b165036827298a14b500b42"><gtr:id>fe2e48115b165036827298a14b500b42</gtr:id><gtr:otherNames>Gerry CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>585d79f39644f9.86300050</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/L003325/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>